Burkholderia cepacia complex infection in patients with cystic fibrosis: laboratory investigations, epidemiology and clinical management

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Reviews in Medical Microbiology

• Publication date

  2003-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00013542-200301000-00002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: A pilot study in a Sydney clinic

  2002cited by this paper
• Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.

  2002cited by this paper
• Direct PCR Detection of Burkholderia cepacia Complex and Identification of Its Genomovars by Using Sputum as Source of DNA

  2002cited by this paper
• Comparative Assessment of Genotyping Methods for Epidemiologic Study of Burkholderia cepacia Genomovar III

  2002cited by this paper
• Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

  2002influential reference
• Burkholderia cepacia complex infection in patients with cystic fibrosis.

  2002cited by this paper
• Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.

  2002cited by this paper
• Burkholderia cepacia Complex Bacteria from Clinical and Environmental Sources in Italy: Genomovar Status and Distribution of Traits Related to Virulence and Transmissibility

  2002cited by this paper
• Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex.

  2002cited by this paper
• Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis.

  2002cited by this paper
• Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre

  2002cited by this paper
• Six-Year Molecular Analysis of Burkholderia cepacia Complex Isolates among Cystic Fibrosis Patients at a Referral Center for Lung Transplantation

  2002cited by this paper
• Taxonomy and Identification of the Burkholderia cepacia Complex

  2001cited by this paper
• Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.

  2001cited by this paper
• Phenotypic Methods for Determining Genomovar Status of the Burkholderia cepacia Complex

  2001cited by this paper
• Burkholderia cepacia Genomovar III Is a Common Plant-Associated Bacterium

  2001cited by this paper
• Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis.

  2001cited by this paper
• Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.

  2001influential reference
• Culture-Based and Non-Growth-Dependent Detection of the Burkholderia cepacia Complex in Soil Environments

  2001cited by this paper
• Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

  2001cited by this paper
• Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.

  2001cited by this paper
• Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.

  2001cited by this paper
• Flagellin gene PCR-RFLP analysis of a panel of strains from the Burkholderia cepacia complex.

  2001cited by this paper
• Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.

  2001cited by this paper
• Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.

  2001cited by this paper
• Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.

  2001cited by this paper
• Burkholderia cepacia Complex Infection in Italian Patients with Cystic Fibrosis: Prevalence, Epidemiology, and Genomovar Status

  2001influential reference
• Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?

  2001cited by this paper
• Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids

  2001cited by this paper
• Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

  2000cited by this paper
• Identification and Population Structure ofBurkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV)

  2000cited by this paper
• Utility of Commercial Systems for Identification ofBurkholderia cepacia Complex from Cystic Fibrosis Sputum Culture

  2000cited by this paper
• Cepacia syndrome occurring following prolonged colonisation with Burkholderia cepacia.

  2000cited by this paper
• Distribution of Genes Encoding Putative Transmissibility Factors among Epidemic and Nonepidemic Strains ofBurkholderia cepacia from Cystic Fibrosis Patients in the United Kingdom

  2000cited by this paper
• DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III

  2000cited by this paper
• Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

  2000cited by this paper
• Differentiation of Burkholderia Species by PCR-Restriction Fragment Length Polymorphism Analysis of the 16S rRNA Gene and Application to Cystic Fibrosis Isolates

  1999cited by this paper
• An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis.

  1999cited by this paper
• Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients

  1999cited by this paper
• Comparison of Isolation Media for Recovery of Burkholderia cepacia Complex from Respiratory Secretions of Patients with Cystic Fibrosis

  1999cited by this paper
• Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis.

  1999cited by this paper
• Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis fromBurkholderia cepacia Genomovars I, III, and IV by PCR

  1999cited by this paper
• Burkholderia cepacia in cystic fibrosis. Variable disease course.

  1999cited by this paper
• Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.

  1999cited by this paper
• Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.

  1999cited by this paper
• Identification of Burkholderia spp. in the Clinical Microbiology Laboratory: Comparison of Conventional and Molecular Methods

  1999cited by this paper
• Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients.

  1998cited by this paper
• Comparison of Culture and PCR for Detection of Burkholderia cepacia in Sputum Samples of Patients with Cystic Fibrosis

  1998cited by this paper
• Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia

  1998cited by this paper
• Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth.

  1998cited by this paper
• Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium

  1997cited by this paper
• Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

  1997cited by this paper
• Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens

  1997cited by this paper
• Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis

  1996cited by this paper
• Lack of evidence of nosocomial cross-infection byBurkholderia cepacia among danish cystic fibrosis patients

  1996cited by this paper
• Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting

  1996cited by this paper
• Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.

  1996cited by this paper
• Burkholderia (Pseudomonas) cepacia: surface chemistry and typing methods

  1995cited by this paper
• Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

  1995cited by this paper
• Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers

  1995cited by this paper
• Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates

  1995cited by this paper
• The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

  1995cited by this paper
• Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping.

  1995cited by this paper
• Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.

  1995cited by this paper
• Detection of Pseudomonas (Burkholderia) cepacia using PCR

  1995cited by this paper
• Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia.

  1994cited by this paper
• Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis

  1993cited by this paper
• Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping

  1992cited by this paper
• Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.

  1992cited by this paper
• Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

  1992cited by this paper
• DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak

  1991cited by this paper
• Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom.

  1990cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989influential reference
• Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations.

  1989cited by this paper
• Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

  1988cited by this paper
• Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis

  1985cited by this paper
• Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

  1985cited by this paper
• Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

  1985cited by this paper
• Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

  1984cited by this paper
• Emendation of the Description of Pseudomonas cepacia Burkholder (Synonyms: Pseudomonas multivorans Stainer et al., Pseudomonas kingae Jonsson; EO-1 Group)

  1975cited by this paper
• Nucleic Acid Homologies in the Genus Pseudomonas

  1973cited by this paper
• Sour skin, a bacterial rot of Onion bulbs.

  1950cited by this paper

• Skin and soft tissue infections

  2021cites this paper
• Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections

  2014cites this paper
• Aerosol phage therapy for in vivo Burkholderia cepacia complex respiratory infections

  2013cites this paper
• Dissecting novel virulent determinants in the Burkholderia cepacia complex

  2012cites this paper
• Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.

  2012influential citation
• Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages

  2012cites this paper
• Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia Complex

  2009cites this paper
• Toward Modern Inhalational Bacteriophage Therapy: Nebulization of Bacteriophages of Burkholderia cepacia Complex

  2008cites this paper
• Lipopolysaccharide as a major virulence factor in the pathogenesis of Burkholderia cepacia syndrome

  2008cites this paper
• Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4‐mediated MAPK signalling pathways and activation of NFκB

  2007cites this paper
• Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization.

  2006cites this paper
• Burkholderia cepacia complex infection in cystic fibrosis patients: mechanisms of pathogenesis

  2004cites this paper